Skip to content
Innovative Tech
Diseases
Health Policy
HTA
Data Analysis
Clinical Practice
Contributors
BACK TO MAIN SITE
Sustainable Pricing in Diabetes: Cost-Effective...
By
HEOR Staff Writer
May 9, 2024
Introduction: The escalating burden of diabetes across the globe is a clarion call for a re-evaluation of medication pricing. With an est...
Biosimilar Competition and Patient Out-of-Pocket Costs
Life Sciences Summit Finalists Set to Transform Healthcare
An Update on The Economic Impact of Adult Immunisation
Economics in Clinical Trials: A Guide to Value-Based Decisions
Clinical Trials in Saudi Arabia: An Insight from PDC-CRO
Anifrolumab in Systemic Lupus Erythematosus Management
Precision Medicine: A New Paradigm in Healthcare
Willingness to Pay for Innovative Oncology Treatments
The Socioeconomic Impact of Cervical Cancer in the UK
CHMP’s February 2024 Meeting: New Drug Recommendations
A Look at Saudi Arabia’s Pharmaceutical Market in 2024
Health Technology Access Pool (HTAP) by the WHO
« Previous
1
…
3
4
5
6
7
Next »